164 related articles for article (PubMed ID: 11889596)
1. Microcalcifications of breast cancer and atypical cystic lobules associated with infiltration of foam cells expressing osteopontin.
Oyama T; Sano T; Hikino T; Xue Q; Iijima K; Nakajima T; Koerner F
Virchows Arch; 2002 Mar; 440(3):267-73. PubMed ID: 11889596
[TBL] [Abstract][Full Text] [Related]
2. Atypical cystic lobule of the breast: an early stage of low-grade ductal carcinoma in-situ.
Oyama T; Iijima K; Takei H; Horiguchi J; Iino Y; Nakajima T; Koerner F
Breast Cancer; 2000; 7(4):326-31. PubMed ID: 11114859
[TBL] [Abstract][Full Text] [Related]
3. Expression of parathyroidlike protein in normal, proliferative, and neoplastic human breast tissues.
Liapis H; Crouch EC; Grosso LE; Kitazawa S; Wick MR
Am J Pathol; 1993 Oct; 143(4):1169-78. PubMed ID: 8214010
[TBL] [Abstract][Full Text] [Related]
4. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta.
Ikeda T; Shirasawa T; Esaki Y; Yoshiki S; Hirokawa K
J Clin Invest; 1993 Dec; 92(6):2814-20. PubMed ID: 8254036
[TBL] [Abstract][Full Text] [Related]
6. Expression of bone matrix protein messenger ribonucleic acids in human breast cancers. Possible involvement of osteopontin in development of calcifying foci.
Hirota S; Ito A; Nagoshi J; Takeda M; Kurata A; Takatsuka Y; Kohri K; Nomura S; Kitamura Y
Lab Invest; 1995 Jan; 72(1):64-9. PubMed ID: 7837792
[TBL] [Abstract][Full Text] [Related]
7. [Role of osteopontin in the formation of microcalcifications in breast cancer].
Tókés AM; Krausz J; Kulka J; Jäckel M; Kádár A
Orv Hetil; 2002 Aug; 143(31):1841-6. PubMed ID: 12187578
[TBL] [Abstract][Full Text] [Related]
8. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
9. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
Latta EK; Tjan S; Parkes RK; O'Malley FP
Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
[TBL] [Abstract][Full Text] [Related]
10. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53].
Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603
[TBL] [Abstract][Full Text] [Related]
11. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
12. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
Piubello Q; Montemezzi S; D'Atri C
Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
[TBL] [Abstract][Full Text] [Related]
13. Basal cell-specific and hyperproliferation-related keratins in human breast cancer.
Wetzels RH; Kuijpers HJ; Lane EB; Leigh IM; Troyanovsky SM; Holland R; van Haelst UJ; Ramaekers FC
Am J Pathol; 1991 Mar; 138(3):751-63. PubMed ID: 1705754
[TBL] [Abstract][Full Text] [Related]
14. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
[TBL] [Abstract][Full Text] [Related]
15. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155
[TBL] [Abstract][Full Text] [Related]
16. Cystic hypersecretory carcinoma: rare and poorly recognized variant of intraductal carcinoma of the breast. Report of five cases.
Skalova A; Ryska A; Kajo K; Di Palma S; Kinkor Z; Michal M
Histopathology; 2005 Jan; 46(1):43-9. PubMed ID: 15656885
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of clusterin in human breast carcinoma.
Redondo M; Villar E; Torres-Muñoz J; Tellez T; Morell M; Petito CK
Am J Pathol; 2000 Aug; 157(2):393-9. PubMed ID: 10934144
[TBL] [Abstract][Full Text] [Related]
18. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Bircan S; Kapucuoglu N; Baspinar S; Inan G; Candir O
Pathol Res Pract; 2006; 202(8):569-76. PubMed ID: 16828238
[TBL] [Abstract][Full Text] [Related]
19. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S
Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207
[TBL] [Abstract][Full Text] [Related]
20. Immunohistological localisation of human FAT1 (hFAT) protein in 326 breast cancers. Does this adhesion molecule have a role in pathogenesis?
Kwaepila N; Burns G; Leong AS
Pathology; 2006 Apr; 38(2):125-31. PubMed ID: 16581652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
